MTOR and metabolic syndrome: This cytokine plays a central role in various pathways and dysfunctions associated with MetS, including IR, through mechanisms involving the activation of the mammalian target of rapamycin (mTOR) and protein kinase C (PKC), as well as systemic inflammation [34].